Latest news

Thumbnail image for US approves second CAR-T therapy

US approves second CAR-T therapy

Gilead’s Yescarta - recently acquired through its purchase of Kite Pharma - has become the second gene therapy to be approved by the US Food and Drug Administration, offering a new treatment approach for patients with certain types of large B-cell lymphoma.

19th October 2017

Thumbnail image for GP referrals to Weight Watchers cut diabetes risk

GP referrals to Weight Watchers cut diabetes risk

More than one third of patients referred by GPs to Weight Watchers in a bid to stave off diabetes saw their blood sugar levels return to normal, a study published in the British Medical Journal has found.

18th October 2017

Thumbnail image for New analysis backs use of Takeda’s Entyvio

New analysis backs use of Takeda’s Entyvio

Takeda has presented data from a post-hoc analysis showing signs of early symptomatic improvement in patients with ulcerative colitis or Crohn’s disease taking Entyvio.

18th October 2017

Thumbnail image for PRIME status for Ignyta’s entrectinib

PRIME status for Ignyta’s entrectinib

European regulators have awarded Ignyta’s cancer drug entrectinib Priority Medicines (PRIME) designation, potentially placing the treatment on a faster path to approval.

18th October 2017

Thumbnail image for ‘No-deal’ Brexit could cost NHS £500m a year

‘No-deal’ Brexit could cost NHS £500m a year

A ‘no-deal’ Brexit that ends healthcare arrangements between the UK and the EU could end up costing the NHS as much as £500 million a year, warns a new paper published by the Brexit Healthcare Alliance, on the back of an analysis by the Nuffield Trust.

17th October 2017

Thumbnail image for Promising data for Sanofi, Regeneron’s dupilumab

Promising data for Sanofi, Regeneron’s dupilumab

Sanofi and Regeneron have unveiled positive results from a mid-stage study exploring the potential of the biologic dupilumab in adults with eosinophilic esophagitis, and also signed a deal with Aimmune Therapeutics to test an experimental peanut allergy therapy.

17th October 2017

Thumbnail image for CHMP backs one generic and six label extensions

CHMP backs one generic and six label extensions

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended just one generic medicine for approval at its October meeting.

16th October 2017

Thumbnail image for AI could bring £630bn to UK by 2035

AI could bring £630bn to UK by 2035

Artificial Intelligence has the potential to add £630 billion to the UK economy by 2035, concludes an independent review commissioned by the government as part of its Industrial Strategy.

16th October 2017

Previous  --   16 17 18 19 20 21 22 23 24 25   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download